Veranome’s Spatial Analyzer (VSA-1) is a fully automated spatial transcriptomics system for reliable, high throughput cyclic FISH assays. Available now, Veranome’s Spatial Analyzer, Model VSA-1, is the first and only system adapting proven semiconductor process control technology to ensure the highest quality data with throughput configurable for both individual and core lab operations. New product […]

Seattle, WA – RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company developing and manufacturing proprietary platforms enabling precision biology solutions, announced today the completion of a $24M financing from new and existing investors. The funding will drive the commercialization and applications for the Company’s new Orion spatial biology platform and further global expansion […]

Three new manufacturing lines were successfully launched in under ten months, with an additional eight new lines planned to launch in Q3 2022. Sustain and secure the supply chain for customers in China and the broader region.  With the use of Fortem™ film, Cytiva helps customers speed up their clinical manufacturing and product launches; improve manufacturing […]

Kadia joins Board as an Independent Director who brings significant expertise in commercializing disruptive life science technologies EMERYVILLE, Calif. — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Siddhartha Kadia, Ph.D. joined the Berkeley Lights Board of Directors as an independent director, effective September 7, 2021. “I am excited […]

Today, LGC announces that Euan O’Sullivan has been appointed Chief Executive Officer (CEO) of the organisation with immediate effect. Euan succeeds Tim Robinson, who will become Chairman of LGC having served as Chief Executive since May 2013. After joining LGC in 2007 as a Non-Executive Director, Euan served as Corporate Development Director from July 2010 […]

Delivers expanded heme-onc menu and the ability to analyze low-input samples  SOUTH SAN FRANCISCO — Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced two key improvements to the core capabilities of its Tapestri Platform intended to expand its accessibility and utility in the area of hematologic oncology (heme-onc) research. These […]

Company plans to expand research and development and scale commercial organization to support global customer base  BOSTON, MA — Emulate, Inc., a leading provider of next generation in vitro models, today announced the close of an $82 million Series E financing round led by existing investor Northpond Ventures with additional participation from Perceptive Advisors. With this investment, Emulate has raised nearly $225 million to date. “This […]

– Masterflex® is a leading global manufacturer of peristaltic pumps and aseptic single-use fluid transfer technologies – Strengthens Avantor’s offering across all bioproduction platforms including mAbs, cell and gene therapy and mRNA, and supports both therapy and vaccine manufacturing including COVID-19 – Transaction is expected to enhance Avantor’s revenue growth and margin profile and be […]

VERNON HILLS, Ill. — Antylia Scientific, a global leader in peristaltic and single use bioprocessing solutions as well as a diverse portfolio of life sciences and diagnostic products for the pharma, biopharma, healthcare and environmental markets, announced today that it has reached a definitive agreement to sell its Masterflex® Bioprocessing business and related assets to […]

Chicago, IL — GTCR, a leading private equity firm, announced today that its Antylia Scientific portfolio company (“Antylia” or the “Company”) has reached a definitive agreement to sell its Masterflex business unit to Avantor for $2.9 billion in an all-cash transaction. In executing its Leaders Strategy™, GTCR acquired Antylia in partnership with CEO Bernd Brust […]